Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Progression of Bladder Cancer”

42 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 42 results

Not applicableUnknownNCT05704231
What this trial is testing

The Effect of Telephone-Assisted Smoking Cessation Program in Patients Diagnosed With Non-Muscle Invasive Bladder Cancer

Who this might be right for
Non-Muscle Invasive Bladder CancerSelf EfficacySmoking Behaviors+2 more
Bakirkoy Dr. Sadi Konuk Research and Training Hospital 60
Testing effectiveness (Phase 2)Ended earlyNCT03652298
What this trial is testing

Effects of a Neuroscience-based Technique on Cancer Patients Announced of a Palliative Disease Progression and Partners

Who this might be right for
Colorectal CancerBladder CancerProstate Cancer+2 more
Centre Oscar Lambret 19
Not applicableNot Yet RecruitingNCT06982690
What this trial is testing

Anesthesia Modality and Oncologic Outcomes in High-Risk NMIBC: A Randomized Trial

Who this might be right for
NMIBCTURBTBladder (Urothelial, Transitional Cell) Cancer+3 more
National Taiwan University Hospital 370
Not applicableUnknownNCT03121768
What this trial is testing

A New Prognostic Model for Predicting the Outcome of Patients With Non-muscle Invasive Bladder Cancer (NMIBC)

Who this might be right for
OncologyBladder CancerSuperficial Bladder Cancer+3 more
Mansoura University 761
Testing effectiveness (Phase 2)Ended earlyNCT00447226
What this trial is testing

Randomized Discontinuation Study of Lapatinib Versus Placebo in Subjects With Documented Tumor Progression After Chemotherapy, or Where no Approved Therapy Exists

Who this might be right for
Cancer
GlaxoSmithKline 32
Early research (Phase 1)Study completedNCT03053635
What this trial is testing

Intravesical Photodynamic Therapy (PDT) in BCG Refractory High-Risk Non-muscle Invasive Bladder Cancer (NMIBC) Patients

Who this might be right for
Non-Muscle Invasive Bladder Cancer (NMIBC) Refractory to BCG
Theralase® Technologies Inc. 6
Testing effectiveness (Phase 2)Study completedNCT00088946
What this trial is testing

Erlotinib and Green Tea Extract (Polyphenon® E) in Preventing Cancer Recurrence in Former Smokers Who Have Undergone Surgery for Bladder Cancer

Who this might be right for
Bladder Cancer
Jonsson Comprehensive Cancer Center 17
Large-scale testing (Phase 3)Looking for participantsNCT07106762
What this trial is testing

Phase 2/3 Trial of Izalontamab Brengitecan vs Platinum-based Chemotherapy for Metastatic Urothelial Cancer With Disease Progression on or After Immunotherapy

Who this might be right for
Urothelial Cancer
Bristol-Myers Squibb 470
Testing effectiveness (Phase 2)Active Not RecruitingNCT05712356
What this trial is testing

LSTA1 When Added to Standard of Care Versus Standard of Care Alone in Patients With Advanced Solid Tumors

Who this might be right for
CholangiocarcinomaGallbladder CancerGallbladder Carcinoma+5 more
Lisata Therapeutics, Inc. 67
Testing effectiveness (Phase 2)Looking for participantsNCT06733363
What this trial is testing

A Cruciferous Vegetable Eating Program for the Reduction of Cancer Recurrence and Progression in Patients With Non-muscle Invasive Bladder Cancer

Who this might be right for
Non-Muscle Invasive Bladder CarcinomaRecurrent Bladder CarcinomaRecurrent Non-Muscle Invasive Bladder Carcinoma+2 more
Roswell Park Cancer Institute 344
Testing effectiveness (Phase 2)Study completedNCT01328574
What this trial is testing

TRC105 in Adults With Advanced/Metastatic Urothelial Carcinoma

Who this might be right for
Urothelial CarcinomaUreteral NeoplasmsUreter Cancer+2 more
National Cancer Institute (NCI) 13
Not applicableUnknownNCT02716961
What this trial is testing

Transurethral Resection of Bladder Tumor (TURBT) Combined With Adjuvant Intravenous GC Chemotherapy for Non-muscle-invasive Bladder Cancer

Who this might be right for
Bladder CancerGemcitabine and Cisplatin ChemotherapyEpirubicin Instillation+2 more
The First Affiliated Hospital with Nanjing Medical University 208
Testing effectiveness (Phase 2)Looking for participantsNCT07322263
What this trial is testing

Intravesical GEM/DOCE for HR BCG-Unresponsive NMIBC

Who this might be right for
Bladder CancerNon-Muscle Invasive Bladder Cancer (NMIBC)Urothelial Carcinoma+8 more
Michael A. O'Donnell 174
Not applicableUnknownNCT03138824
What this trial is testing

Storz Professional Image Enhancement System Versus White Light Imaging Assisted TURBT for Treatment of NMIBC

Who this might be right for
Bladder Urothelial CarcinomaTURBTBladder Neoplasm+1 more
Mansoura University 100
Large-scale testing (Phase 3)UnknownNCT00146276
What this trial is testing

Adjuvant Versus Progression-Triggered Gemcitabine Monotherapy for Locally Advanced Bladder Cancer

Who this might be right for
Bladder CancerCarcinoma, Transitional Cell
Association of Urologic Oncology (AUO) 178
Not applicableStudy completedNCT04028479
What this trial is testing

The Registry of Oncology Outcomes Associated With Testing and Treatment

Who this might be right for
AdenocarcinomaAdenocystic CarcinomaAnal Cancer+73 more
Taproot Health 167
Not applicableLooking for participantsNCT07424560
What this trial is testing

Multiplex Mutation Detection Using Mass Spectrometry in Bladder Cancer

Who this might be right for
Bladder CancerBladder Cancer RecurrenceAdjuvant Therapy for Bladder Cancer+1 more
Zhilong Dong 400
Large-scale testing (Phase 3)Study completedNCT00406068
What this trial is testing

Mycobacterial Cell Wall-DNA Complex in Treatment of BCG-refractory Patients With Non-muscle Invasive Bladder Cancer

Who this might be right for
Bladder Neoplasms
Bioniche Life Sciences Inc. 129
Not applicableStudy completedNCT04723121
What this trial is testing

Can We Predict of the Response of High Risk Non Muscle Invasive Bladder Cancer Patients to Intravesical Bacillus Calmette-Guerin? The Role of Immunological Markers

Who this might be right for
Bladder Cancer
Mansoura University 204
Very early researchEnded earlyNCT03266900
What this trial is testing

A Superiority Trial to Compare Re-resection of High-grade T1 Bladder Urothelial Carcinoma to no Re-resection for Improving Progression Free Survival

Who this might be right for
Bladder CancerBladder Urothelial Carcinoma
University Health Network, Toronto 2
Load More Results